Dissolving Microneedle Formulation of Ceftriaxone: Effect of Polymer Concentrations on Characterisation and Ex Vivo Permeation Study
Tóm tắt
This study aimed to develop dissolving microneedle preparations containing ceftriaxone and evaluate the effect of polymer concentrations on characterisation and ex vivo permeation study. The microneedles were prepared using centrifugation method with different ratios of PVP40% and PVA15%, namely FB1 (50:50), FB2 (60:40), and FB3 (70:30). The microneedles were also prepared with various concentrations of ceftriaxone, namely 10% w/w, 15% w/w, and 20% w/w. The microneedles were evaluated for their mechanical properties and ex vivo permeation profiles. The results showed that the microneedles were in the form of sharp pyramid with size ranging between 712 and 800 μm. The concentration of ceftriaxone was found to affect the mechanical properties of the microneedles where formulations containing 20% w/w of ceftriaxone could not be produced. To achieve high drug loading, 15% w/w of ceftriaxone was selected in this study. Following the microneedle preparations, the formulation containing 15% w/w of ceftriaxone with FB3 polymer mixture exhibited the best mechanical properties with only 12.96 ± 0.56% height reduction after the compression with 30 N pressure. Moreover, this formulation was able to penetrate 4 layers of Parafilm® layers, indicating adequate insertion properties. Importantly, the microneedles were found to dissolve completely after 10 min on the full thickness rat skin. The permeation study showed that the greater the concentration of PVA, the slower the permeation of ceftriaxone from the microneedles. The highest drug permeation was obtained by containing 15% w/w of ceftriaxone with PVP40%:PVA15% with the ratio of 70:30, with the percentage of 99.86 ± 7.6%. The stability studies showed that the microneedles were stable for 1 month in two humidity levels, namely RH 43% and RH 86%. Variation of polymer concentration exhibited a significant effect on the mechanical properties of microneedles. The permeation test showed that the greater the concentration of PVA, the slower the permeation of the active substance from dissolving microneedle. Further studies should be conducted to perform in vivo pharmacokinetic studies.
Tài liệu tham khảo
WHO. Pneumonia. 2019 In: https://www.who.int/news-room/fact-sheets/detail/pneumonia (accessed on 30 Dec 2020).
Windi RF, EfendiQona’ah A, Adnani QES, Ramadhan K, Almutairi WM. Determinants of acute repiratory infection among children under-five years in Indonesia. J Pediatr Nurs. 2021.
Ramya CM. Bacterial pneumonia. Res J Pharm Technol. 2014;7:942–5. https://doi.org/10.5005/jp/books/10485_24.
WHO. Newborns: reducing mortality. 2020 In: https://www.who.int/news-room/fact-sheets/detail/newborns-reducing-mortality.
Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, MacE SE, McCracken GH, Moore MR, St Peter SD, Stockwell JA, Swanson JT. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011;53:25–76. https://doi.org/10.1093/cid/cir531.
Kauss T, Marchivie M, Phoeung T, Gaubert A, Désiré A, Tonelli G, Boyer C, Langlois MH, Cartwright A, Gomes M, White N, Gaudin K. Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations. Eur J Pharm Sci. 2017;104:382–92. https://doi.org/10.1016/j.ejps.2017.04.010.
MohdY K, Roy M, Rawal RK, Bansal UK. A review-ceftriaxone for life. Asian Journal of Pharmaceutical Research. 2017;7:35. https://doi.org/10.5958/2231-5691.2017.00007.7.
Cho SW, Lee JS, Choi SH. Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of Absorption Carrier for the Ceftriaxone Complex. J Pharm Sci. 2004;93:612–20. https://doi.org/10.1002/jps.10563.
Kanwal T, Kawish M, Maharjan R, Ghaffar I, Ali HS, Imran M, Perveen S, Saifullah S, Simjee SU, Shah MR. Design and development of permeation enhancer containing self-nanoemulsifying drug delivery system (SNEDDS) for ceftriaxone sodium improved oral pharmacokinetics. J Mol Liq. 2019;289:111098. https://doi.org/10.1016/j.molliq.2019.111098.
Saeed A, AL-Japairai K, Mahmood S, HamedAlmurisi S, Reddy Venugopal J, RebhiHilles A, Azmana M, Raman S. Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587:119673. https://doi.org/10.1016/j.ijpharm.2020.119673.
Nagarkar R, Singh M, Nguyen HX, Jonnalagadda S. A review of recent advances in microneedle technology for transdermal drug delivery. J Drug Delivery Sci Technol. 2020;59:101923. https://doi.org/10.1016/j.jddst.2020.101923.
Permana AD, Anjani QK, Sartini UE, Volpe-Zanutto F, Paredes AJ, Evary YM, Mardikasari SA, Pratama MR, Tuany IN, Donnelly RF. Selective delivery of silver nanoparticles for improved treatment of biofilm skin infection using bacteria-responsive microparticles loaded into dissolving microneedles. Mater Sci Eng C. 2021;120:111786. https://doi.org/10.1016/j.msec.2020.111786.
Permana AD, Mir M, Utomo E, Donnelly RF. Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study. Int J Pharm. 2020;2:100047. https://doi.org/10.1016/j.ijpx.2020.100047.
Requena MB, Permana AD, Vollet-Filho JD, González-Vázquez P, Garcia MR, de Faria CMG, Pratavieira S, Donnelly RF, Bagnato VS. Dissolving microneedles containing aminolevulinic acid improves protoporphyrin IX distribution. J Biophotonics. 2021;14:e202000128. https://doi.org/10.1002/jbio.202000128.
Permana AD, Nainu F, Moffatt K, Larrañeta E, Donnelly RF. Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery. WIREs Nanomed Nanobiotechnol. 2021;13:e1690. https://doi.org/10.1002/wnan.1690.
Cheng H, Liu M, Du X, Xu J, Zhai Y, Ji J, He S, Zhai G. Recent progress of micro-needle formulations: fabrication strategies and delivery applications. J Drug Delivery Sci Technol. 2019;50:18–26. https://doi.org/10.1016/j.jddst.2019.01.002.
González-Vázquez P, Larrañeta E, McCrudden MTC, Jarrahian C, Rein-Weston A, Quintanar-Solares M, Zehrung D, McCarthy H, Courtenay AJ, Donnelly RF. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. J Control Release. 2017;265:30–40. https://doi.org/10.1016/j.jconrel.2017.07.032.
Dharadhar S, Majumdar A, Dhoble S, Patravale V. Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm. 2019;45:188–201. https://doi.org/10.1080/03639045.2018.1539497.
Parhi R, Supriya ND. Review of microneedle based transdermal drug delivery systems. Int J Pharm Sci Nanotechnol. 2019;12:4511–23. https://doi.org/10.37285/ijpsn.2019.12.3.1.
Permana AD, Tekko IA, McCrudden MTC, Anjani QK, Ramadon D, McCarthy HO, Donnelly RF. Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. J Control Release. 2019;316:34–52. https://doi.org/10.1016/j.jconrel.2019.10.004.
Permana AD, McCrudden MTC, Donnelly RF. Enhanced intradermal delivery of nanosuspensions of antifilariasis drugs using dissolving microneedles: a proof of concept study. Pharmaceutics. 2019;11. https://doi.org/10.3390/pharmaceutics11070346.
Permana AD, Paredes AJ, Volpe-Zanutto F, Anjani QK, Utomo E, Donnelly RF. Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis. Eur J Pharm Biopharm. 2020;154:50–61. https://doi.org/10.1016/j.ejpb.2020.06.025.
Singh A, Bali A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol. 2016;7:1–13. https://doi.org/10.1186/s40543-016-0105-6.
Disha N, Gurupadayya B. Stability indicating HPLC method for the simultaneous determination of ceftriaxone and vancomycin in pharmaceutical formulation. J Chromatogr Sep Tech. 2013;04. https://doi.org/10.4172/2157-7064.1000207.
Hutton ARJ, Quinn HL, McCague PJ, Jarrahian C, Rein-Weston A, Coffey PS, Gerth-Guyette E, Zehrung D, Larrañeta E, Donnelly RF. Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding. Int J Pharm. 2018;541:56–63. https://doi.org/10.1016/J.IJPHARM.2018.02.031.
Volpe-Zanutto F, Ferreira LT, Permana AD, Kirkby M, Paredes AJ, Vora LK, Bonfanti PA, Charlie-Silva II, Raposo C, Figueiredo MC, Sousa IMO, Brisibe A, Costa FTM, Donnelly RF, Foglio MA. Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii. J Control Release. 2021;333:298–315. https://doi.org/10.1016/j.jconrel.2021.03.036.
Guillot AJ, Cordeiro AS, Donnelly RF, Montesinos MC, Garrigues TM, Melero A. Microneedle-based delivery: an overview of current applications and trends. Pharmaceutics. 2020;12:569. https://doi.org/10.3390/pharmaceutics12060569.
Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, Dua K. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249–58. https://doi.org/10.1016/j.biopha.2018.10.078.
Wang QL, Ren JW, Chen BZ, Jin X, Zhang CY, Guo XD. Effect of humidity on mechanical properties of dissolving microneedles for transdermal drug delivery. J Ind Eng Chem. 2018;59:251–8. https://doi.org/10.1016/j.jiec.2017.10.030.
Choudhary S, Sengwa RJ. ZnO nanoparticles dispersed PVA–PVP blend matrix based high performance flexible nanodielectrics for multifunctional microelectronic devices. Curr Appl Phys. 2018;18:1041–58. https://doi.org/10.1016/j.cap.2018.05.023.
Teodorescu M, Bercea M, Morariu S. Biomaterials of PVA and PVP in medical and pharmaceutical applications: perspectives and challenges. Biotechnol Adv. 2019;37:109–31. https://doi.org/10.1016/j.biotechadv.2018.11.008.
Larrañeta E, Moore J, Vicente-Pérez EM, González-Vázquez P, Lutton R, Woolfson AD, Donnelly RF. A proposed model membrane and test method for microneedle insertion studies. Int J Pharm. 2014;472:65–73. https://doi.org/10.1016/j.ijpharm.2014.05.042.
Shim WS, Hwang YM, Park SG, Lee CK, Kang NG. Role of polyvinylpyrrolidone in dissolving microneedle for efficient transdermal drug delivery: in vitro and clinical studies. Bull Korean Chem Soc. 2018;39:789–93. https://doi.org/10.1002/bkcs.11476.
Shu Z, Cao Y, Tao Y, Liang X, Wang F, Li Z, Li Z, Gui S. Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism. Drug Deliv. 2020;27:642–51. https://doi.org/10.1080/10717544.2020.1754524.